{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:50:24Z","timestamp":1760907024540,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["OC130500"],"award-info":[{"award-number":["OC130500"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015582","name":"Ovarian Cancer Academy","doi-asserted-by":"crossref","award":["OC160444"],"award-info":[{"award-number":["OC160444"]}],"id":[{"id":"10.13039\/100015582","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.hoc.2018.07.013","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T12:21:40Z","timestamp":1541074900000},"page":"915-928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Frontiers in the Pathology and Pathogenesis of Ovarian Cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Thing Rinda","family":"Soong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela M.","family":"Dinulescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wa","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2018.07.013_bib1","series-title":"Diagnostic gynecologic and obstetric pathology","first-page":"865","article-title":"The pathology of pelvic-ovarian (epithelial-stromal) tumors","author":"Howitt","year":"2018"},{"key":"10.1016\/j.hoc.2018.07.013_bib2","first-page":"1235","article-title":"Closing in on a breast cancer gene on chromosome 17q","volume":"50","author":"Hall","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2018.07.013_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","article-title":"Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations","volume":"76","author":"Zweemer","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/modpathol.2016.238","article-title":"Serous tubal intraepithelial neoplasia: the concept and its application","volume":"30","author":"Meserve","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","article-title":"Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas","volume":"39","author":"Gilks","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2017.04.015","article-title":"Frequency of \"incidental\" serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: a six-year study","volume":"146","author":"Meserve","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib9","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1471-0528.14543","article-title":"Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review","volume":"124","author":"Chen","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.hoc.2018.07.013_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2741\/S401","article-title":"The origin of ovarian cancers--hypotheses and controversies","volume":"5","author":"Auersperg","year":"2013","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.hoc.2018.07.013_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.1995.tb01528.x","article-title":"p53 protein expression in putative precursor lesions of epithelial ovarian cancer","volume":"27","author":"Hutson","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.hoc.2018.07.013_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.1998.5275","article-title":"The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?","volume":"72","author":"Dubeau","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fonc.2013.00296","article-title":"Current status and evolution of preclinical drug development models of epithelial ovarian cancer","volume":"3","author":"Konstantinopoulos","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib14","doi-asserted-by":"crossref","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2018.07.013_bib15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2017.09.027","article-title":"Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer","volume":"147","author":"Matsuo","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nm1173","article-title":"Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer","volume":"11","author":"Dinulescu","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.hoc.2018.07.013_bib17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.humpath.2008.01.003","article-title":"Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma","volume":"39","author":"Gilks","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/PAS.0b013e31819c4271","article-title":"Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases","volume":"33","author":"Veras","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"9 Suppl 3","key":"10.1016\/j.hoc.2018.07.013_bib20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IGC.0000000000000289","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary","volume":"24","author":"Okamoto","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2018.07.013_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/modpathol.2014.61","article-title":"Napsin A is a specific marker for ovarian clear cell adenocarcinoma","volume":"28","author":"Yamashita","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humpath.2016.01.011","article-title":"Genetic analysis results of mature cystic teratomas of the ovary in Taiwan disagree with the previous origin theory of this tumor","volume":"52","author":"Wang","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nm1230","article-title":"Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract","volume":"11","author":"Cheng","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.hoc.2018.07.013_bib24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.5858\/132.11.1753","article-title":"Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors","volume":"132","author":"Seidman","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.hoc.2018.07.013_bib25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/00000478-200011000-00001","article-title":"Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'","volume":"24","author":"Lee","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"9 Suppl 3","key":"10.1016\/j.hoc.2018.07.013_bib26","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/IGC.0000000000000296","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinoma","volume":"24","author":"Ledermann","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.hoc.2018.07.013_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/PAS.0b013e31820508d0","article-title":"Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors","volume":"35","author":"Meriden","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1440-1827.2011.02670.x","article-title":"Pyloric gland metaplasia\/differentiation in multiple organ systems in a patient with Peutz-Jeghers syndrome","volume":"61","author":"Kato","year":"2011","journal-title":"Pathol Int"},{"key":"10.1016\/j.hoc.2018.07.013_bib29","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/1097-0142(197511)36:5<1709::AID-CNCR2820360526>3.0.CO;2-7","article-title":"Mucinous tumors of the ovary. Ultrastructural studies of mucinous cystadenomas with histogenetic considerations","volume":"36","author":"Fenoglio","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2018.07.013_bib30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/1097-0142(19880201)61:3<546::AID-CNCR2820610321>3.0.CO;2-I","article-title":"Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of Mullerian type. A clinicopathologic analysis","volume":"61","author":"Rutgers","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2018.07.013_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/PAS.0000000000000812","article-title":"Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary","volume":"41","author":"Rambau","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004347-200301000-00010","article-title":"Ovarian mucinous and mixed epithelial carcinomas of Mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis","volume":"22","author":"Lee","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib33","article-title":"Ovarian cancer statistics, 2018","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2018.07.013_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib35","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO;2-W","article-title":"Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis","volume":"62","author":"Bell","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2018.07.013_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2016.05.036","article-title":"Endosalpingiosis: more than just an incidental finding at the time of gynecologic surgery?","volume":"142","author":"Esselen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/beog.2002.0300","article-title":"Pathology of borderline (low malignant potential) ovarian tumours","volume":"16","author":"Seidman","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.hoc.2018.07.013_bib38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2016.11.007","article-title":"A\u00a0nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma","volume":"144","author":"Hannibal","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib39","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e318233b0f7","article-title":"Fallopian tube correlates of ovarian serous borderline tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib40","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","article-title":"Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis","volume":"35","author":"Kurman","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2009.03.001","article-title":"Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant","volume":"114","author":"Gershenson","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2018.07.013_bib42","doi-asserted-by":"crossref","first-page":"i45","DOI":"10.1093\/annonc\/mdw085","article-title":"Low-grade serous carcinoma of the ovary or peritoneum","volume":"27","author":"Gershenson","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nature15716","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"527","author":"Patch","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.hoc.2018.07.013_bib45","article-title":"Current gaps in ovarian cancer epidemiology: the need for new population-based research","volume":"109","author":"Doherty","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2018.07.013_bib46","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.hoc.2018.07.013_bib47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"23","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.hoc.2018.07.013_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A\u00a0candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/modpathol.2010.171","article-title":"The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls","volume":"24","author":"Mehra","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ygyno.2018.01.016","article-title":"Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: a survey of U.S. laboratory practices","volume":"148","author":"Samimi","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2018.07.013_bib56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/AOG.0000000000002243","article-title":"The evolution of and evidence for opportunistic salpingectomy","volume":"130","author":"Dilley","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.hoc.2018.07.013_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2018.07.013_bib58","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib59","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.humpath.2012.12.007","article-title":"Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?","volume":"44","author":"Gao","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib60","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s13224-017-1009-0","article-title":"Serous tubal carcinogenesis: the recent concept of origin of ovarian, primary peritoneal and fallopian tube high-grade serous carcinoma","volume":"67","author":"Kar","year":"2017","journal-title":"J\u00a0Obstet Gynaecol India"},{"key":"10.1016\/j.hoc.2018.07.013_bib61","article-title":"Evidence of a monoclonal origin for bilateral serous tubal intraepithelial neoplasia","author":"Meserve","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/path.5145","article-title":"Evidence for lineage continuity between early serous proliferations (ESPs) in the fallopian tube and disseminated high-grade serous carcinomas","author":"Soong","year":"2018","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib63","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000369","article-title":"Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.07.013_bib64","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib65","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\"Primary peritoneal\" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.hoc.2018.07.013_bib66","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:12:22Z","timestamp":1760184742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858818307639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0889858818307639"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2018.07.013","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frontiers in the Pathology and Pathogenesis of Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2018.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}